Diagnostics & Tools March 2019

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

• Transactions in the Diagnostics & Tools industry totaled fifteen mergers & acquisitions and twenty-four financings during the month of March
• In terms of M&A, Diagnostic Services was the most active this month, with 6 transactions; while in terms of financing, Life Science Tools was the most active, with 9 financings
• Total disclosed M&A value was $76.3 million, while financings totaled $134.4 million during the month of March
• The largest disclosed M&A transaction this month was the $65 million acquisition of Geneva Healthcare by BioTelemetry, Inc. while the largest financing was $52.6 million raised by Inivata
• M&A and financings in the United States accounted for 67% and 63% of total transactions this month, down 8% and up 67%, respectively
• M&A activity this month includes acquisitions by Laboratory Corporation of America, BioTelemetry, and Precision for Medicine and Guardant Health